Bionik Laboratories (BNKL) Inventory Turnover Ratio, from fourth quarter 2023 to fourth quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Bionik Laboratories Corp   (BNKL)
 

Bionik Laboratories Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bionik Laboratories Corp inventory turnover ratio, the Bionik Laboratories Corp 's ability to sell and replace its inventory in the fourth quarter 2023, sequentially increased to 0.66 in the fourth quarter 2023, yet the ratio remained below the average, as BNKL's market remain challenging.Average inventory processing period, for the Bionik Laboratories in Mar 31 2023 quarter, has decreased to 553 days, compare to 745 days, in the Dec 31 2022 quarter.

Within Healthcare sector 396 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2023, to 1920, from total ranking in the third quarter 2023 at 2044.

BNKL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bionik Laboratories Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BNKL Inventory Turnover Ratio (Mar 31 2023)
IV. Quarter		 (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter
Y / Y Inventory Growth -13.14 % 23.07 % 71.2 % 136.02 % 72.07 %
Y / Y Cost of Sales Growth 321.27 % 504.17 % 133.12 % -42.39 % -54 %
Inventory Turnover Ratio (TTM) 0.66 0.49 0.3 0.25 0.37
BNKL's Total Ranking # 1920 # 2044 # 1299 # 2071 # 1549
Average inventory processing period 554 743 1197 1490 1000
Seq. Inventory Growth -9.54 % -15.33 % -4.84 % 19.16 % 28.18 %
Seq. Cost of Sales Growth -18.89 % 61.41 % 150.92 % 28.23 % 16.33 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 169
Healthcare Sector # 397
Overall Market # 1920

Inventory Turnover Ratio Statistics
High Average Low
5.98 1.62 0.25
(Mar 31 2019)   (Jun 30 2022)



BNKL Company Profile >> Back to BNKL Efficiency Comparisons >> Compare BNKL Inventory Turnover Ratio to its Competitors

Financial Statements
Bionik Laboratories 's Inventories $ 1 Millions Visit BNKL's Balance sheet
Bionik Laboratories 's Cost of Revenues TTM $ 1 Millions Visit BNKL's Income Statement
What are BNKL's Sales? Visit BNKL's Sales by Segment

Other Inventory Turnover Ratios
Bionik Laboratories 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BNKL's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BNKL's Competitors
Inventory Turnover Ratio for BNKL's Suppliers
Inventory Turnover Ratio for BNKL's Customers

You may also want to know
BNKL's Sales Growth Rates BNKL's Pe Price to earnings ratio BNKL's Receivables Turnover Ratio BNKL's Stock Quote
BNKL's Net Income Growth Rates BNKL's Ps Price to Sales ratio BNKL's Sales per Employee BNKL's Asset Turnover Ratio
BNKL's Net Margin BNKL's Pb Price to Book ratio BNKL's Financial Strength Ratios BNKL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2023 Inventories at quarter ending Mar 31 2023
Orthofix Medical Inc   2.16 $ 160.309  Millions$ 74  Millions
Retractable Technologies Inc  2.15 $ 44.377  Millions$ 21  Millions
Inotiv Inc   2.11 $ 146.755  Millions$ 69  Millions
Enzo Biochem Inc  2.10 $ 29.625  Millions$ 14  Millions
Trevena inc   2.10 $ 2.938  Millions$ 1  Millions
Coherus Oncology inc   2.10 $ 77.587  Millions$ 37  Millions
Sonendo Inc   2.10 $ 31.122  Millions$ 15  Millions
Sight Sciences Inc   2.09 $ 12.376  Millions$ 6  Millions
Milestone Scientific Inc   2.09 $ 3.595  Millions$ 2  Millions
Surgalign Holdings Inc   2.09 $ 41.355  Millions$ 20  Millions
Axsome Therapeutics Inc   2.07 $ 12.754  Millions$ 6  Millions
Elite Pharmaceuticals Inc   2.07 $ 16.200  Millions$ 8  Millions
Resmed Inc   2.06 $ 1,732.889  Millions$ 841  Millions
Biolase Inc   2.05 $ 34.244  Millions$ 17  Millions
Haemonetics Corporation  2.04 $ 553.000  Millions$ 271  Millions
Cutera Inc   2.03 $ 119.238  Millions$ 59  Millions
Pressure Biosciences Inc   2.01 $ 2.058  Millions$ 1  Millions
Conformis inc   2.01 $ 36.761  Millions$ 18  Millions
Lifeloc Technologies Inc   2.01 $ 5.317  Millions$ 3  Millions
Immucell Corporation  2.00 $ 11.168  Millions$ 6  Millions
Thorne Healthtech Inc   2.00 $ 120.211  Millions$ 60  Millions
Glaukos Corp  2.00 $ 69.987  Millions$ 35  Millions
Atricure Inc   1.99 $ 89.343  Millions$ 45  Millions
Macrogenics Inc   1.98 $ 3.416  Millions$ 2  Millions
Rxsight Inc   1.98 $ 29.619  Millions$ 15  Millions
Journey Medical Corp  1.98 $ 29.021  Millions$ 15  Millions
Fortress Biotech Inc   1.98 $ 29.021  Millions$ 15  Millions
Koru Medical Systems Inc   1.97 $ 13.151  Millions$ 7  Millions
Aurinia Pharmaceuticals Inc   1.96 $ 5.829  Millions$ 3  Millions
Acorda Therapeutics Inc   1.94 $ 27.599  Millions$ 14  Millions

Date modified: 2026-09-08T15:10:58+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.